OTIBIOVIN
OTIBIOVIN
Authorised
- Salicylic acid
- Triamcinolone
- Gentamicin
- CARBETHOPENDECINII BROMIDUM
Product identification
Medicine name:
OTIBIOVIN
Active substance:
- Salicylic acid
- Triamcinolone
- Gentamicin
- CARBETHOPENDECINII BROMIDUM
Target species:
-
Dog
-
Cat
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Salicylic acid5.00/milligram(s)1.00millilitre(s)
-
Triamcinolone0.50/milligram(s)1.00millilitre(s)
-
Gentamicin2.00/milligram(s)1.00millilitre(s)
-
CARBETHOPENDECINII BROMIDUM0.13/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Cutaneous solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD01AE12
- QD07AB09
- QD08AJ
- QS02AA14
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 150391
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/12/2021
How useful was this page?:
